RTW Biotech Opportunities appoints Baroness Nicola Blackwood to its Board as Independent Director

– USA, NY –  RTW Biotech Opportunities Ltd (LON: RTW & RTWG), an investment company focused on identifying transformative assets with high growth potential across the life sciences sector, announced the appointment of Baroness Nicola Blackwood to its Board as an Independent Non-Executive Director, effective the 11th of July 2024.

About Baroness Nicola Blackwood

Nicola Blackwood is a leader in science and entrepreneurship. She is a member of the House of Lords and Chair of Genomics England and Oxford University Innovation. Since 2023, she has been a Supervisory Board member of the biotechnology company, BioNTech. Nicola Blackwood served as Minister for Innovation in the Department for Health and Social Care under two Prime Ministers where she led on Lifesciences, NHS Data and Digital Transformation, and Global Health Security. She was the first female MP for Oxford and was elected by MPs of all parties to Chair the Commons Science and Tech Committee. She remains one of the youngest committee chairs in British history and the only woman to have chaired the Commons Science & Tech Committee.

Nicola Blackwood said, “I am delighted to be joining the RTW Biotech Opportunities Ltd Board. Life sciences and innovation will be central in tackling many of the global challenges we face today. I look forward to engaging with the RTW team and playing a part in powering innovations from breakthrough to high-growth companies.”

About Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to supporting innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

For more information: https://www.rtwfunds.com/rtw-biotech-opportunities-ltd/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.